<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04945512</url>
  </required_header>
  <id_info>
    <org_study_id>2020/1831</org_study_id>
    <nct_id>NCT04945512</nct_id>
  </id_info>
  <brief_title>Efficacy of Epidural Analgesia in Lower Extremity Osteosarcoma</brief_title>
  <official_title>Efficacy of Epidural Analgesia Initiated in the Preoperative Period in Lower Extremity Osteosarcoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators aim to reduce complications in orthopedic malignancy&#xD;
      surgeries and to increase the quality of life of patients who will be operated on.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the preoperative period, the participants will be taken to the block room. The&#xD;
      participants will be monitored, standard sedation will be applied.&#xD;
&#xD;
      Patients in the first group will be provided with preoperative and peroperative analgesia&#xD;
      with an epidural catheter. The second group patient will be get no block. Afterwards, both&#xD;
      groups will be operated under similar general anesthesia conditions. A patient-controlled&#xD;
      analgesia device will be attached to each group of participants and their postoperative&#xD;
      follow-up will be made.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 7, 2021</start_date>
  <completion_date type="Anticipated">September 20, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 20, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Study group and control group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>48 hours</time_frame>
    <description>miligram</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of postoperative pain</measure>
    <time_frame>48 hours</time_frame>
    <description>VAS (visual analog scale) (0: no pain, 10: the worst pain imaginable)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Amount of peroperative bleeding</measure>
    <time_frame>During surgery</time_frame>
    <description>Mililiter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of postoperative bleeding</measure>
    <time_frame>48 Hours</time_frame>
    <description>Mililiter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>postoperative period up to 3 days</time_frame>
    <description>yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive care unit stay</measure>
    <time_frame>48 hours</time_frame>
    <description>hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>72 hours</time_frame>
    <description>hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>Will be done 3 times 1- a day after surgery 2- in the 1st week follow up after surgery 3- in the 1st month follow-up after surgery</time_frame>
    <description>5-point Likert scale: very satisfied (= 5), satisfied (= 4), neutral (= 3), dissatisfied (= 2) and very dissatisfied (= 1)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory (BDI)</measure>
    <time_frame>Will be done 2 times 1- on pre-operative hospitalization 2- in the 1st month follow-up after surgery]</time_frame>
    <description>0-9: indicates minimal depression 10-18: indicates mild depression 19-29: indicates moderate depression 30-63: indicates severe depression</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Osteosarcoma</condition>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>Study group; Epidural catheter and PCA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epidural catheter will be placed in the preoperative period. After induction, 10 ml of 0.25% bupivacaine will be administered through the epidural catheter and bupivacaine PCA will be started.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group; No block, IC PCA</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Postoperative pain control will be achieved with intravenous morphine PCA.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural Analgesia</intervention_name>
    <description>In the anesthesia preparation room, an epidutal catheter will be placed with a toue needle through the L4-5 spinal space. After induction of general anesthesia, 10 ml of 0.25% bupivacaine will be injected through the epidural catheter.Afterwards, peroperative and postoperative analgesia will be provided with epidural PCA.</description>
    <arm_group_label>Study group; Epidural catheter and PCA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  accepting the study protocol,&#xD;
&#xD;
          -  age older than 18 years and younger than 80 years,&#xD;
&#xD;
          -  undergoing lower extremity osteosarcoma surgery&#xD;
&#xD;
          -  the American Society of Anesthesiologist (ASA) physical status of I-II-III&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  infection at the injection site&#xD;
&#xD;
          -  coagulation disorder&#xD;
&#xD;
          -  patients with central nervous system related disease&#xD;
&#xD;
          -  septic patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gizem Toydemir, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul Unıversity, Istanbul Faculty of Medicine, Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nur Canbolat, MD</last_name>
    <phone>+905325162583</phone>
    <email>drnurekiz@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mehmet Büget, Assoc. Prof.</last_name>
    <phone>+905324133282</phone>
    <email>mbuget@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Istanbul University, Faculty of Medicine</name>
      <address>
        <city>Istanbul</city>
        <state>Fatih</state>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nur Canbolat, MD</last_name>
      <email>drnurekiz@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Mehmet Büget, Assoc. Prof</last_name>
      <email>mbuget@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Nur Canbolat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mehmet Büget, Assoc. Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gizem Toydemir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Rawal N. Current issues in postoperative pain management. Eur J Anaesthesiol. 2016 Mar;33(3):160-71. doi: 10.1097/EJA.0000000000000366. Review.</citation>
    <PMID>26509324</PMID>
  </results_reference>
  <results_reference>
    <citation>Weinbroum AA. Superiority of postoperative epidural over intravenous patient-controlled analgesia in orthopedic oncologic patients. Surgery. 2005 Nov;138(5):869-76.</citation>
    <PMID>16291387</PMID>
  </results_reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 8, 2021</study_first_submitted>
  <study_first_submitted_qc>June 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 30, 2021</study_first_posted>
  <last_update_submitted>November 7, 2021</last_update_submitted>
  <last_update_submitted_qc>November 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Nur Canbolat</investigator_full_name>
    <investigator_title>Principle Invastigator, M.D.</investigator_title>
  </responsible_party>
  <keyword>epidural analgesia</keyword>
  <keyword>lower extremity osteosarcoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteosarcoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

